or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    NTBL F Notable Labs, Ltd. 0.00
    TCBP F TC BioPharm (Holdings) plc -3.16
    MJ F ETFMG Alternative Harvest ETF 0.59
    IMTX F Immatics N.V. 0.33
    DTIL F Precision BioSciences, Inc. 13.16
    HRTX F Heron Therapeutics, Inc. 2.83
    ENLV F Enlivex Therapeutics Ltd. 4.04
    NKTX F Nkarta, Inc. -1.43
    EFTR F eFFECTOR Therapeutics, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Medicine Solid Tumors Antineoplastic Drugs Biotechnology Diabetes Melanoma Orphan Drug ATM Advanced Non Small Cell Lung Cancer Affinity Groups Annuity Products Asset Management Products Atrial Fibrillation Bemcentinib Biopharmaceutical Products Bladder Cancer Blastoma

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    JFWD B Jacob Funds Inc. Jacob Forward ETF 2.78
    CNCR F Loncar Cancer Immunotherapy ETF 0.93
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 0.55
    FPXE D First Trust IPOX Europe Equity Opportunities ETF 0.31
    QQQS C Invesco NASDAQ Future Gen 200 ETF 0.31
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare BBC to FPXE Compare BBC to QQQS Compare CNCR to QQQS

        Cancer Treatment Stocks Recent News

        Date Stock Title
        Nov 22 NKTX Nkarta price target lowered to $16 from $20 at Mizuho
        Nov 21 DTIL Precision BioSciences to Participate in Upcoming November Investor Conferences
        Nov 20 IMTX Immatics N.V. (NASDAQ:IMTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
        Nov 19 IMTX Immatics Sees Revenue Surge Despite R&D Expenses
        Nov 18 IMTX Immatics GAAP EPS of -€0.11, revenue of €50.56M
        Nov 18 IMTX Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Medicine Solid Tumors Antineoplastic Drugs Biotechnology Diabetes Melanoma Orphan Drug ATM Advanced Non Small Cell Lung Cancer Affinity Groups Annuity Products Asset Management Products Atrial Fibrillation Bemcentinib Biopharmaceutical Products Bladder Cancer Blastoma
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags